Multi-gene risk-score for prediction of clinical outcomes in treatment-naïve metastatic castrate resistant prostate ...
To determine the performance of a multi-gene copy number variation (MG-CNV) risk score in metastatic tissue and plasma biospecimens from treatment-naïve metastatic castrate-resistant prostate cancer (mCRPC) patients for prediction of clinical outcomes. …